Skip to main content
Robert Zipkin, MD, Cardiology, Burlingame, CA, Mills-Peninsula Medical Center

RobertEliotZipkinMD

Cardiology Burlingame, CA

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Are you Dr. Zipkin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 66 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Robert Zipkin, MD is a cardiologist in Burlingame, California. He is currently licensed to practice medicine in California. He is affiliated with Mills-Peninsula Medical Center.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1988 - 1991
  • Kaiser Permanente Northern California (San Francisco)
    Kaiser Permanente Northern California (San Francisco)Residency, Internal Medicine, 1987 - 1988
  • California Pacific Medical Center
    California Pacific Medical CenterResidency, Internal Medicine, 1985 - 1987
  • University of California Davis Health
    University of California Davis HealthInternship, Internal Medicine, 1984 - 1985
  • University of California, Davis, School of Medicine
    University of California, Davis, School of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012

Publications & Presentations

PubMed

Grant Support

  • Tyrosine Phosphatase Inhibitors As New ImmunomodulatorsNational Institute Of Allergy And Infectious Diseases1993
  • Farnesyltransferase Inhibitors As Anticancer AgentsNational Cancer Institute1993
  • Novel Anticancer Drugs Based On Glycolipid DepletionNational Cancer Institute1992
  • Novel Therapeutic Agents For Myocardial InfarctionNational Heart, Lung, And Blood Institute1990
  • Radioimmunoassay Kits For Platelet Activating FactorNational Heart, Lung, And Blood Institute1988
  • Radioimmunoassay Kits For Leukotriene MetabolitesNational Heart, Lung, And Blood Institute1986

Other Languages

  • Spanish, French, Hebrew

Hospital Affiliations